Filing Details

Accession Number:
0001042167-22-000038
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-08-17 18:01:25
Reporting Period:
2022-08-15
Accepted Time:
2022-08-17 18:01:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
863894 Veru Inc. VERU Pharmaceutical Preparations (2834) 391144397
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1689094 Mario Eisenberger 2916 North Miami Avenue, Suite 1000
Miami FL 33127
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-08-15 45,000 $1.20 45,000 No 4 M Direct
Common Stock Acquisiton 2022-08-15 5,000 $1.50 50,000 No 4 M Direct
Common Stock Acquisiton 2022-08-15 5,000 $2.08 55,000 No 4 M Direct
Common Stock Acquisiton 2022-08-15 45,000 $1.89 100,000 No 4 M Direct
Common Stock Disposition 2022-08-15 100,000 $20.04 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Option Disposition 2022-08-15 45,000 $0.00 45,000 $1.20
Common Stock Common Stock Option Disposition 2022-08-15 5,000 $0.00 5,000 $1.50
Common Stock Common Stock Option Disposition 2022-08-15 5,000 $0.00 5,000 $2.08
Common Stock Common Stock Option Disposition 2022-08-15 45,000 $0.00 45,000 $1.89
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-08-02 2027-08-02 No 4 M Direct
0 2020-03-26 2029-03-26 No 4 M Direct
0 2019-08-17 2028-08-17 No 4 M Direct
0 2019-05-02 2028-05-02 No 4 M Direct
Footnotes
  1. The price reported above is the weighted average transaction price. The range of prices for such transactions is $20.00 to $20.21. Upon request by the Commission, staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
  2. All shares underlying this option have been vested.